Mallinckrodt pharma pays record $35 mill. for failure to report suspicious orders of drugs

Mallinckrodt LLC, pharmaceutical manufacturer and one of the largest producers of oxycodone will pay $35 Million settling assertions that it violated the Controlled Substances Act (CSA) says the DOJ. The government alleged that Mallinckrodt failed to design and implement an effective system to detect and report "suspicious orders" for controlled substances "Ʊ orders that...
Continue reading…

New CMS data reveals: Pharma and device companies paid $8.2 billion to doctors and hospitals last year

According to newly released data from the Centers for Medicare and Medicaid Services (CMS), pharmaceutical and medical device companies paid over $8.2 Billion to doctors and hospitals in 2016, mostly for research and for things like enrolling patient into new clinical studies and carrying on those studies. The research payments also went to compensate...
Continue reading…

Securities and Exchange Commission charge 2 Ariad Pharma employees with insider trading

The Securities and Exchange Commission charged two former senior employees  of Ariad Pharmaceuticals, Inc. with insider trading aheadof announcements about U.S. Food and Drug Administration decisions involving main cancer drug. According to the SEC’s complaint, Harold Altvater, whose wife was an Ariad employee, allegedly made multiple illegal trades in Ariad stock on...
Continue reading…

Missouri Attorney General Sues 3 big pharma makers of opioids alleging fraud

Missouri Whistleblower News Missouri Attorney General Josh Hawley filed a lawsuit today against three large drug manufacturing companies in the Circuit Court of St. Louis City. Hawley is suing Purdue Pharma, Endo Health Solutions and Janssen Pharmaceuticals. The lawsuit alleges that these companies fraudulently misrepresented the serious risks posed by the drugs they manufacture and...
Continue reading…

Walgreens pays $50 million to settle claim it violated anti-kickback law. whistleblower gets $9.7 million

Companies, including pharmacies and their parent entities are frequently trying to find ways to attract the buying public to purchase their pharma products rather than from their competition. However, the law does not allow beneficiaries of government health insurance programs like Medicare, Medicaid or TriCare to receive anything of value in return for their...
Continue reading…